In contrast, studies performed in the BEAT-PD study cohort did not find differences in the peripheral immune profile (no cellular or cytokines alterations) among patients with PD and mutations in LRRK2 and GBA genes nor in non-manifesting carriers of these mutations47,48. This evidence concerns the gene LRRK2 and Parkinson disease.